Question 1

What is Quantum BioPharma?

Accepted Answer

Quantum BioPharma is a Entity.

Question 2

How often does Quantum BioPharma appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 8 articles.

Question 3

When was Quantum BioPharma first tracked by Ergen?

Accepted Answer

First tracked on Jun 02, 2026.

Question 4

When was Quantum BioPharma last mentioned in news?

Accepted Answer

Last active on Jun 25, 2026.

Question 5

What is Quantum BioPharma's current news sentiment?

Accepted Answer

Aggregate sentiment score: 75 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Quantum BioPharma in global news coverage?

Accepted Answer

Attention score of 6, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Quantum BioPharma?

Accepted Answer

Quantum BioPharma Advances Lucid-MS to Phase 2 (Jun 08, 2026, 8 articles).

Question 8

How did the "Quantum BioPharma Advances Lucid-MS to Phase 2" event impact Quantum BioPharma?

Accepted Answer

Quantum BioPharma is the biopharmaceutical company developing Lucid-MS, a patented drug candidate for multiple sclerosis, and is advancing it into phase 2 clinical trials. This event highlights the company's progress and potential in addressing an unmet medical need.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.